Abstract

Parmacoepidemiological studies that use medical information databases are powerful tools for post-marketing drug safety assessment. Recently, some medical information databases including claims data and electronic medical records data have become available in Japan. To conduct optimum drug safety assessment, researchers should comprehend the strengths and limitations of such databases. This paper deals with two important methodological topics in the field of pharmacoepidemiological ; causal inference and self-controlled methods. Also, pharmacoepidemiological studies may be important to find out rare serious adverse events of drugs, although few studies have focused on drug safety assessment in small animal medicine.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.